Publications
Detailed Information
Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, J. | - |
dc.contributor.author | Koh, J. K. | - |
dc.contributor.author | Lee, E. Y. | - |
dc.contributor.author | Park, J. A. | - |
dc.contributor.author | Lee, E. B. | - |
dc.contributor.author | Cotena, A. | - |
dc.contributor.author | Song, Y. W. | - |
dc.contributor.author | Garlanda, C. | - |
dc.contributor.author | Kim, H. A. | - |
dc.date.accessioned | 2012-06-26T04:44:20Z | - |
dc.date.available | 2012-06-26T04:44:20Z | - |
dc.date.issued | 2009-10 | - |
dc.identifier.citation | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; Vol.27 5; 773-778 | ko_KR |
dc.identifier.issn | 0392-856X | - |
dc.identifier.uri | https://hdl.handle.net/10371/77419 | - |
dc.description.abstract | Objective To investigate the role of sTREM-1 and PTX3 as markers of injection in febrile patients with SLE Methods In febrile (body temperature >= 38 degrees C) patients with SLE, blood samples of day 0, 1, 2, and 14 after presentation were drawn and relevant clinical data were, collected. The patients were allocated to an infection group (n=19) or disease flare group (n=14). Serum levels of sTREM-1 and PTX3 were measured by ELISA using the serum samples of SLE patients and age-and sex-matched healthy controls (n=31). Results A total of 33 febrile episodes occurred in 32 SLE patients (19 infections, 14 flares) were studied. sTREM-1 levels oil day 0 were, significantly higher in the infection group than in the flare group (109.9 pg/ml (median) vs. 48.0 pg/ml, p=0.002), but PTX3 levels were similar in these two groups. The difference of sTREM-1 levels between infection group and flare group was persistent on day 1 and 2 (day 1, p=0.007; day 2, p=0.034). The highest diagnostic value (sensitivity=1.0, specificity=0.664) of sTREM-1 was obtained at the threshold value of 53.2 pg/mL. Conclusion Sertan sTREM-1 levels were significantly higher in the infection group than in the flare group of febrile SLE patients. Our findings suggest that serum sTREM-1 levels could be used to determine whether SLE patients have contracted an infection. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | CLINICAL & EXPER RHEUMATOLOGY | ko_KR |
dc.subject | Human TREM1 protein | ko_KR |
dc.subject | PTX3 protein | ko_KR |
dc.subject | fever | ko_KR |
dc.subject | systemic lupus erythematosus | ko_KR |
dc.title | Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus | ko_KR |
dc.type | Article | ko_KR |
dc.citation.journaltitle | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | - |
dc.description.citedreference | Ippolito A, 2008, CLIN EXP RHEUMATOL, V26, pS72 | - |
dc.description.citedreference | Keenan RT, 2008, CLIN EXP RHEUMATOL, V26, P814 | - |
dc.description.citedreference | WALLACE DJ, 2007, DUBOIS LUPUS ERYTHEM, P638 | - |
dc.description.citedreference | GINZLER EM, 2007, DUBOIS LUPUS ERYTHEM, P901 | - |
dc.description.citedreference | Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7 | - |
dc.description.citedreference | Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A | - |
dc.description.citedreference | Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756 | - |
dc.description.citedreference | WILLIAMS RC, 2005, J RHEUMATOL, V32, P454 | - |
dc.description.citedreference | al-Ramadi BK, 2004, CLIN IMMUNOL, V112, P221, DOI 10.1016/j.clim.2004.03.012 | - |
dc.description.citedreference | Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544 | - |
dc.description.citedreference | KIM T, 2004, ADV STUD CONT MATH, V9, P15 | - |
dc.description.citedreference | Colonna M, 2003, J INFECT DIS, V187, pS397 | - |
dc.description.citedreference | Shin KC, 2001, ANN RHEUM DIS, V60, P988 | - |
dc.description.citedreference | Cohen J, 2001, LANCET, V358, P776 | - |
dc.description.citedreference | Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017 | - |
dc.description.citedreference | Nathan C, 2001, NAT MED, V7, P530 | - |
dc.description.citedreference | Bouchon A, 2001, NATURE, V410, P1103 | - |
dc.description.citedreference | Roy S, 2001, RHEUMATOLOGY, V40, P349 | - |
dc.description.citedreference | Peri G, 2000, CIRCULATION, V102, P636 | - |
dc.description.citedreference | Bouchon A, 2000, J IMMUNOL, V164, P4991 | - |
dc.description.citedreference | Espinosa-Morales R, 1998, ARTHRITIS RHEUM, V41, P567 | - |
dc.description.citedreference | Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725 | - |
dc.description.citedreference | Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250 | - |
dc.description.citedreference | BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630 | - |
dc.description.citedreference | TERBORG EJ, 1990, J RHEUMATOL, V17, P1642 | - |
dc.description.citedreference | MACKIEWICZ A, 1987, ARTHRITIS RHEUM, V30, P513 | - |
dc.description.citedreference | INOUE T, 1986, RHEUMATOL INT, V6, P69 | - |
dc.description.citedreference | HIND CRK, 1985, ANN RHEUM DIS, V44, P260 | - |
dc.description.citedreference | PEPYS MB, 1982, CLIN RHEUM DIS, V8, P91 | - |
dc.description.citedreference | BECKER GJ, 1980, ANN RHEUM DIS, V39, P50 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.